SAI LIFE SCIENCES LIMITED (SAILIFE) Share Price Hits 52-Week High

SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high of Rs 1,408.65, rising 1.1% today. The market capitalisation stands at Rs 28,963.4 crore.

SAI LIFE SCIENCES LIMITED Share Price has reached a fresh 52-week high of Rs 1,408.65, marking a 1.1% increase from the previous close of Rs 1,393.35. This rise highlights the stock's upward momentum in the market. With a market capitalisation of Rs 28,963.4 crore, SAI LIFE SCIENCES LIMITED is drawing investor attention. The stock opened at Rs 1,403.85 and fluctuated between a low of Rs 1,388.25 and the new high. The turnover for the day was Rs 0.2 crore, with a volume of 1,396 shares traded.

SAI LIFE SCIENCES LIMITED Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,408.65
Previous Close	Rs 1,393.35
Today's Change	+Rs 15.3 (+1.1%)
Day Open	Rs 1,403.85
Fresh 52-Week High	Rs 1,408.65
Day Low	Rs 1,388.25
Current Volume	1,396
Turnover	Rs 0.2 crore
Market Capitalisation	Rs 28,963.4 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) traded at Rs 1,408.65. versus the previous close of Rs 1,393.35, a rise of 1.1%. The stock opened at Rs 1,403.85, reached Rs 1,408.65, touched Rs 1,388.25. Reported volume was 1,396.

Today, SAI LIFE SCIENCES LIMITED Share Price opened at Rs 1,403.85 and quickly rose to a new 52-week high of Rs 1,408.65, closing at the same level. The stock's day change was Rs 15.3, representing a 1.1% increase. The day's low was Rs 1,388.25. The turnover reached Rs 0.2 crore, with a volume of 1,396 shares, indicating moderate trading activity. This price action suggests a positive sentiment among investors, as the stock continues to climb.

SAI LIFE SCIENCES LIMITED (SAILIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 28,963.4 crore
P/E Ratio	31.4x
P/B Ratio	0.46x
ROE	-2.89%
ROCE	-0.26%

SAI LIFE SCIENCES LIMITED was valued at a P/E ratio of 31.4x, a P/B ratio of 0.46x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.4x
Benchmark Median P/E	21.61x
Benchmark Average P/E	72.01x
Benchmark P/E Range	0x to 3,428.55x
Company P/B Ratio	0.46x
Benchmark Median P/B	1.92x
Company ROE	-2.89%
Benchmark Median ROE	10.75%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 28,963.4 crore
Benchmark Median Market Cap	Rs 139.72 crore

SAI LIFE SCIENCES LIMITED (SAILIFE) is classified under sector: Healthcare.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 31.4x, which is above the benchmark median of 21.61x, a difference of +45.3%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROE of -2.89%, which is below the benchmark median of 10.75%, a difference of -126.88%. SAI LIFE SCIENCES LIMITED (SAILIFE) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,943.6	31.4	0.46	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,684.11	39.39	8.02	28.21	26.35
Beta Drugs Ltd.	BETA	2,621.81	63.25	10.01	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,511.89	32.96	6.79	-2.6	16.92
Sai Parenteral's Ltd.	SAIPARENT	2,347.02	160.63	2.97	13.9	12.97

SAI LIFE SCIENCES LIMITED (SAILIFE) has a P/E ratio of 31.4x compared with the displayed peer median of 39.39x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. SAI LIFE SCIENCES LIMITED (SAILIFE) has a market capitalisation of Rs 28,963.4 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching SAI LIFE SCIENCES LIMITED

• SAI LIFE SCIENCES LIMITED Share Price reached a fresh 52-week high, indicating strong market interest.
• Valuation metrics show a mixed picture, with a high P/E but low P/B ratio.
• Negative ROE and ROCE highlight profitability concerns.
• The healthcare sector context provides a benchmark for performance evaluation.

About SAI LIFE SCIENCES LIMITED

SAI LIFE SCIENCES LIMITED operates in the healthcare sector, focusing on pharmaceutical research and development. The company is involved in various stages of drug development, offering services from discovery to commercial manufacturing. Its operations are aligned with industry standards, catering to global pharmaceutical companies. Despite its significant market presence, the company faces challenges in profitability, as reflected in its financial metrics.

Track SAI LIFE SCIENCES LIMITED Share Price on Univest

Use SAI LIFE SCIENCES LIMITED (SAILIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track SAI LIFE SCIENCES LIMITED Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest for comprehensive analysis.

Frequently Asked Questions

What is the current share price of SAI LIFE SCIENCES LIMITED?

Ans. The current share price of SAI LIFE SCIENCES LIMITED is Rs 1,408.65, which marks a fresh 52-week high for the stock. The stock moved 1.1% during the session. The intraday range extended from Rs 1,388.25 to Rs 1,408.65.

How much did SAI LIFE SCIENCES LIMITED's share price increase today?

Ans. SAI LIFE SCIENCES LIMITED's share price increased by Rs 15.3 today, representing a 1.1% rise from the previous close. The stock moved 1.1% during the session. The intraday range extended from Rs 1,388.25 to Rs 1,408.65.

What is the market capitalisation of SAI LIFE SCIENCES LIMITED?

Ans. The market capitalisation of SAI LIFE SCIENCES LIMITED is Rs 28,963.4 crore, indicating its significant size in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 31.4x.

How does SAI LIFE SCIENCES LIMITED's P/E ratio compare to the sector median?

Ans. SAI LIFE SCIENCES LIMITED's P/E ratio of 31.4 is above the sector median of 21.61, suggesting a relatively higher valuation. The company trades at a P/E ratio of 31.4x. Its P/B ratio is 0.46x.

What are the ROE and ROCE of SAI LIFE SCIENCES LIMITED?

Ans. SAI LIFE SCIENCES LIMITED has a negative ROE of -2.89% and a negative ROCE of -0.26%, indicating challenges in profitability and efficiency. ROE stands at -2.89%. ROCE stands at -0.26%.

How does SAI LIFE SCIENCES LIMITED's P/B ratio compare to the sector median?

Ans. The P/B ratio of SAI LIFE SCIENCES LIMITED is 0.46, which is significantly lower than the sector median of 1.92, suggesting undervaluation. The company trades at a P/E ratio of 31.4x.

Who are the peers of SAI LIFE SCIENCES LIMITED?

Ans. Peers of SAI LIFE SCIENCES LIMITED include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Beta Drugs Ltd., among others. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd.

How does SAI LIFE SCIENCES LIMITED's market cap compare to its peers?

Ans. SAI LIFE SCIENCES LIMITED's market cap of Rs 28,963.4 crore is significantly higher than its peers, such as Dishman Carbogen Amcis Ltd. and Kwality Pharmaceuticals Ltd. The company operates in the Healthcare sector.

Investor Monitoring and Future Outlook

Investors are closely monitoring SAI LIFE SCIENCES LIMITED due to its recent performance and the broader trends in the healthcare sector. The company's ability to maintain its market position and improve its financial metrics will be crucial for sustaining investor confidence. Given the healthcare sector's dynamic nature, SAI LIFE SCIENCES LIMITED's focus on innovation and strategic partnerships could play a significant role in its future growth trajectory. Investors should keep an eye on any announcements related to new product developments or collaborations that could impact the company's market standing.

Furthermore, the company's valuation metrics, such as its P/E and P/B ratios, suggest that there may be room for growth if the company can address its profitability challenges. The healthcare sector's ongoing evolution, driven by technological advancements and regulatory changes, presents both opportunities and challenges for SAI LIFE SCIENCES LIMITED. As the company navigates these changes, its strategic decisions will be pivotal in shaping its future performance and investor sentiment.